Indonesia Clinical Nutrition Market Report 2023 to 2030

Indonesia Clinical Nutrition Market Analysis

$ 3999

The Indonesia Clinical Nutrition Market was valued at $184 Mn in 2023 and is projected to grow at a CAGR of 5.34% from 2023 to 2023, to $264.9 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Nature’s Sunshine Products, Darya-Varia Laboratoria Tbk, Bio Farma and Citra Nusa Insan Cemerlang.

ID: IN10IDPH569 CATEGORY: Pharmaceuticals GEOGRAPHY: Indonesia AUTHOR: Mahima Reddy

Buy Now

Indonesia Clinical Nutrition Market Executive Summary

The Indonesia Clinical Nutrition Market is at around $184 Mn in 2023 and is projected to reach $264.9 Mn in 2030, exhibiting a CAGR of 5.34% during the forecast period 2023-2030.

Clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The clinical nutrition sector is undergoing a transformation fuelled by progress in medical research and technology. Key trends such as innovative formulations, personalized nutrition solutions, and the use of bioactive ingredients are emerging. Manufacturers are dedicating resources to R&D to produce products that not only fulfil fundamental nutritional requirements but also provide added health advantages. This emphasis on innovation is fostering competition among industry participants, resulting in a constant flow of new products and therapies tailored to various patient demographics.

Clinical nutritionists or registered dietitians work in hospitals, clinics, and other healthcare facilities to, assess patients' nutritional status, develop personalized nutrition plans, provide nutrition education, manage nutrition-related diseases like diabetes, malnutrition etc, support optimal health and well-being. Some areas of focus in clinical nutrition include, critical care nutrition, paediatric nutrition, oncology nutrition, gastrointestinal nutrition, sports nutrition etc.

According to the International Diabetes Federation, the prevalence of diabetes in Indonesia was 6.2% in 2021, affecting approximately 10.7 Mn adults. The major drivers of Clinical Nutrition industry in Indonesia are, increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients.

The market is primarily dominated by local players such as Nature’s Sunshine Products, Darya-Varia Laboratoria Tbk, Bio Farma and Citra Nusa Insan Cemerlang.

Indonesia Clinical Nutrition Market Report 2023 to 2030

Market Dynamics

Market Drivers

Rising Prevalence of Chronic Diseases: Indonesia has seen a significant increase in the prevalence of chronic diseases, such as diabetes and obesity, which require specialized clinical nutrition for management. According to the International Diabetes Federation, the prevalence of diabetes in Indonesia was 6.2% in 2021, affecting approximately 10.7 million adults. This rising burden of chronic diseases is a key driver of the clinical nutrition market in the country.

Improving Healthcare Infrastructure: The Indonesian government has been investing in improving the country's healthcare infrastructure, including the development of specialized medical centres and the adoption of advanced technologies. This has led to an increase in the personalization of medical nutrition solutions, as healthcare professionals can now better assess individual nutritional needs and provide targeted clinical nutrition interventions.

Increasing Demand for Organic and Nutritional Products: There is a growing demand for organic, nutritional, and conventional food products in Indonesia, which is actively supporting the clinical nutrition market growth. Consumers are becoming more conscious about their health and are willing to invest in products that can improve their overall well-being. Thus, boosting the market of clinical nutrition.

Market Restraints

Regulatory Framework: The regulatory framework in Indonesia lacks a distinct category for functional foods, which can create ambiguities and constraints for the clinical nutrition market. The process of registering novel food or nutrition products with health or functional claims can be lengthy and onerous, as it requires a scientific dossier with evidence of health benefits, safety, and quality.

Time and Expense of Registration Process: Due to the time and expense involved in the registration process, functional foods are often launched as ordinary food products without health claims, or bearing only generic healthy-living messages. This can limit the growth of the clinical nutrition market in Indonesia.

Competition from Domestic Herbal Supplements: Domestic herbal supplement products in Indonesia may be regarded as competitors to clinical nutrition products, as they have been experiencing rapid market growth. This competition from traditional and herbal remedies can pose a challenge to the clinical nutrition market, impacting its growth.

Regulatory Landscape and Reimbursement Scenario

Clinical nutrition regulation and reimbursement in Indonesia operate within the country's evolving healthcare system, primarily overseen by the Ministry of Health. The National Agency of Drug and Food Control (BPOM) regulates nutritional products and supplements, while the Indonesian Nutrition Association (PERSAGI) sets professional standards for nutrition practice.

In 2014, Indonesia implemented a universal healthcare coverage system, Jaminan Kesehatan Nasional (JKN), managed by the Social Insurance Administration Organization (BPJS). Under JKN, basic nutritional interventions are generally covered, including primary care nutritional counselling, inpatient nutritional support, and some forms of enteral nutrition when medically necessary. However, coverage for specialized nutritional interventions or long-term therapies is often limited, with many patients facing out-of-pocket expenses for comprehensive care. Private health insurance may offer more extensive coverage, but this varies widely between plans.

Competitive Landscape

Key Players

Here are some of the major key players in the Indonesia Clinical Nutrition Market:

Citra Nusa Insan Cemerlang
Darya-Varia Laboratoria Tbk
Nature’s Sunshine Products
Herbalife Indonesia
Enervon Indonesia
Bio Farma
Kino Indonesia
Mustika Ratu
Metha Lorengau
Xplus Nutrisari
GlaxoSmithKline
Nestle

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Indonesia Clinical Nutrition Market Segmentation

By Product

Oral Clinical Nutrition
Parenteral Nutrition
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solutions
Trace Elements
Vitamins & Minerals
Enteral Feeding Formulas
Standard Formula
Disease-specific Formulas
Others

By Application

Alzheimer’s Disease
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel

Retail Sales Channels
Online Sales Channels
Institutional Sales Channels
Others

End Users

Geriatric
Adults
Paediatric

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.